Biotech & AI drug discoverySTAT — Biotech

STAT+: Roche gets a lung cancer win with its KRAS drug divarasib

Per STAT+, Roche's KRAS-targeting drug divarasib notched a lung cancer win, with a Roche study producing one of the more impressive data sets presented at this year's ESMO meeting.

AI summary · generated only from source feed metadata; consult original

Source published2026-10-26T23:17:13+00:00

Published here2026-10-27T00:04:06+00:00

Original source

STAT — Biotech

Media report · consult original reporting

Read the original ↗https://www.statnews.com/2026/10/26/roche-kras-drug-divarasib-lung-cancer-treatment-win/

Original headline

STAT+: Roche gets a lung cancer win with its KRAS drug divarasib

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.